{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:32:24Z","timestamp":1793705544910,"version":"4.5.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019168","name":"Starship Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019168","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128082","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T20:07:16Z","timestamp":1765051636000},"page":"128082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Impact of a single\u2013dose program on varicella hospitalizations and infectious disease inequity in New Zealand: A retrospective cohort study"],"prefix":"10.1016","volume":"72","author":[{"given":"Michael-John","family":"Fay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma J","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7892","key":"10.1016\/j.vaccine.2025.128082_bb0005","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128082_bb0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2165\/0063030-200822060-00005","article-title":"Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix)","volume":"22","author":"Kreth","year":"2008","journal-title":"BioDrugs"},{"issue":"12","key":"10.1016\/j.vaccine.2025.128082_bb0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3345\/cep.2021.01564","article-title":"Global varicella vaccination programs","volume":"65","author":"Lee","year":"2022","journal-title":"Clin Exp Pediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128082_bb0020","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3741","article-title":"Global varicella vaccine effectiveness: a Meta-analysis","volume":"137","author":"Marin","year":"2016","journal-title":"Pediatrics"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2025.128082_bb0025","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1093\/infdis\/jiac299","article-title":"The effectiveness of varicella vaccine: 25 years of Postlicensure experience in the United States","volume":"226","author":"Shapiro","year":"2022","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2025.128082_bb0030","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/jpc.12937","article-title":"Prospective surveillance of hospitalisations associated with varicella in New Zealand children","volume":"51","author":"Wen","year":"2015","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128082_bb0035","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/jpc.12473","article-title":"Varicella in a paediatric intensive care unit: 10-year review from Starship children's hospital, New Zealand","volume":"50","author":"Wen","year":"2014","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2025.128082_bb0040","series-title":"NZDep2013 Index of Deprivation","author":"Atkinson","year":"2014"},{"key":"10.1016\/j.vaccine.2025.128082_bb0045","series-title":"Evaluation of the implementation of the varicella vaccine introduction","author":"Clarke","year":"2018"},{"key":"10.1016\/j.vaccine.2025.128082_bb0050","series-title":"Initial priorities for the National Immunisation Programme in Aotearoa","author":"Taskforce","year":"2022"},{"key":"10.1016\/j.vaccine.2025.128082_bb0055","series-title":"Ethnicity Data Protocols","author":"Health","year":"2017"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128082_bb0060","first-page":"123","article-title":"The implications of different ethnicity categorisation methods for understanding outcomes and developing policy in New Zealand","volume":"15","author":"Boven","year":"2020","journal-title":"K\u014dtuitui: New Zealand J Social Sci Online"},{"key":"10.1016\/j.vaccine.2025.128082_bb0065","author":"Zealand"},{"key":"10.1016\/j.vaccine.2025.128082_bb0070","series-title":"Review of Health service user population methodology","author":"NZ, S","year":"2022"},{"key":"10.1016\/j.vaccine.2025.128082_bb0075","series-title":"Record of the Immunisation Subcommittee of the Pharmacology and Therapeutics Committee (PTAC) meeting held at PHARMAC on 23 May 2016","author":"PHARMAC","year":"2016"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128082_bb0080","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/cid\/ciy570","article-title":"Pneumococcal conjugate vaccines turning the tide on inequity: a retrospective cohort study of New Zealand children born 2006-2015","volume":"68","author":"Petousis-Harris","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128082_bb0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1440-1754.2010.01969.x","article-title":"Reducing inequalities with vaccines: New Zealand's MeNZB vaccine initiative to control an epidemic","volume":"48","author":"Lennon","year":"2012","journal-title":"J Paediatr Child Health"},{"issue":"8","key":"10.1016\/j.vaccine.2025.128082_bb0090","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/14760584.2022.2075851","article-title":"Real-world impact of rotavirus vaccination in European healthcare settings: a systematic literature review","volume":"21","author":"Bencina","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.128082_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijid.2020.03.051","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on the incidence of hospitalizations for all-cause pneumonia among children aged less than 5 years in Burkina Faso: an interrupted time-series analysis","volume":"96","author":"Kabor\u00e9","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2025.128082_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184204","article-title":"Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: a time-series analysis","volume":"12","author":"Andrade","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128082_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13247","article-title":"Impact of the COVID-19 related border restrictions on influenza and other common respiratory viral infections in New Zealand","volume":"18","author":"Huang","year":"2024","journal-title":"Influenza Other Respir Viruses"},{"issue":"1610","key":"10.1016\/j.vaccine.2025.128082_bb0110","first-page":"74","article-title":"Consequences of COVID-19 protection measures on children's respiratory health in Aotearoa New Zealand","volume":"138","author":"O'Loughlin","year":"2025","journal-title":"N Z Med J"},{"key":"10.1016\/j.vaccine.2025.128082_bb0115","first-page":"46","article-title":"Effect of COVID-19 restrictions and border closures on vaccine preventable diseases in Victoria, Australia, 2020\u20132021","volume":"2022","author":"Bhatt","year":"2018","journal-title":"Commun Dis Intell"},{"issue":"34","key":"10.1016\/j.vaccine.2025.128082_bb0120","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1016\/j.vaccine.2023.06.054","article-title":"Impacts of routine varicella vaccination program and COVID-19 pandemic on varicella and herpes zoster incidence and health resource use among children in Japan","volume":"41","author":"Uda","year":"2023","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128082_bb0125","doi-asserted-by":"crossref","first-page":"489","DOI":"10.32394\/pe.77.40","article-title":"Chickenpox in Poland in 2021","volume":"77","author":"Bogusz","year":"2024","journal-title":"Przegl Epidemiol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.128082_bb0130","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3390\/v16121912","article-title":"Has COVID-19 affected the course of chickenpox in children?","volume":"16","author":"Franczak","year":"2024","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128082_bb0135","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2301626","article-title":"Exploring the impact of the COVID-19 pandemic on perceptions of national scheduled childhood vaccines among M\u0101ori and Pacific caregivers, wh\u0101nau, and healthcare professionals in Aotearoa New Zealand","volume":"20","author":"Charania","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.128082_bb0140","article-title":"Assessing the impact of the COVID-19 pandemic on childhood vaccine uptake with administrative data","volume":"26","author":"Iusitini","year":"2024","journal-title":"SSM Popul Health"},{"issue":"8","key":"10.1016\/j.vaccine.2025.128082_bb0145","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2471\/BLT.13.132142","article-title":"Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study","volume":"92","author":"Heywood","year":"2014","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128082_bb0150","first-page":"220","article-title":"Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program","volume":"78","author":"Quinn","year":"2019","journal-title":"J Inf Secur"},{"key":"10.1016\/j.vaccine.2025.128082_bb0155","series-title":"Canberra: Australian immunisation handbook","year":"2024"},{"key":"10.1016\/j.vaccine.2025.128082_bb0160","series-title":"Childhood immunisation coverage","author":"Care., A.G.D.O.H.A.A","year":"2025"},{"key":"10.1016\/j.vaccine.2025.128082_bb0165","series-title":"Annual childhood immunisation coverage by age, district, region, deprivation, and prioritised ethnicity Q3 2024\/25","author":"Ora","year":"2025"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:58:29Z","timestamp":1768453109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25013805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":33,"alternative-id":["S0264410X25013805"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128082","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of a single\u2013dose program on varicella hospitalizations and infectious disease inequity in New Zealand: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128082"}}